Exact Sciences (EXAS) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

ScreeningPrecision Oncology
0250M500M750M1B1B2B2B2BQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Revenue by Geography

UNITED STATESNon-US
0250M500M750M1B1B2B2B2BQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
0250M500M750M1B1B2B2B2BQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Margin (%)

Gross MarginOperating MarginNet Income Margin
01122344556687990Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Operating Expenses

Research And Development ExpensesSelling And Marketing ExpensesGeneral And Administrative ExpensesOther Expenses
0250M500M750M1B1B2B2B2BQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

EBITDA

EBITDA
-1B-866M-732M-599M-465M-331M-198M-64M70MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

EPS

Revenue Variation (%)

Revenue Variation
-2146912141720Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation
06251K2K2K3K4K4K5KQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Revenue YoY Variation (%)

Revenue YoY Variation
048111519222630Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY VariationNet Income YoY Variation
05001K2K2K2K3K4K4KQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Price-to-Earning Ratio

P/E Ratio
-3K-3K-2K-2K-1K-1K-749-3741Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Income Breakdown

Rule Of 40 (EBITDA)Rule Of 40 (FCF)
01020304050607080Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Per Share Metrics

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
01M2M4M5M6M8M9M10MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Expense Ratios

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
012344567Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025
💰 Cash Flow Statement

Operating Cash Flow

Research And Ddevelopement To RevenueCapex To RevenueStock Based Compensation To Revenue
000001111Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Free Cash Flow

Operating Cash FlowCapital ExpenditureFree Cash Flow
062M125M188M250M312M375M438M500MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Cash Flow to Debt Ratio

Cash At End Of Period
0250M500M750M1B1B2B2B2BQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025
🏦 Balance Sheet
📈 Key Metrics